Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?

Diffuse Large B-Cell Lymphoma (DLBCL) is a clinically and biologically heterogeneous disease. The revised Classification of Lymphoproliferative diseases published in 2016 (WHO, 2016) refined the previous DLBLC subtypes and identified four categories: DLBCL not otherwise specified (NOS), other lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiappella, Annalisa, Crombie, Jennifer, Guidetti, Anna, Vitolo, Umberto, Armand, Philippe, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919463/
https://www.ncbi.nlm.nih.gov/pubmed/31942539
http://dx.doi.org/10.1097/HS9.0000000000000284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919463/
https://www.ncbi.nlm.nih.gov/pubmed/31942539
http://dx.doi.org/10.1097/HS9.0000000000000284

Ejemplares similares